Publicatielijst - Rijksuniversiteit Groningen

List of publications H.J. Woerdenbag
(August 2014)
Scientific publications (peer reviewed)
1. Hendriks H, Bos R, Woerdenbag HJ, Koster ASj. Central nervous depressant activity of
valerenic acid in the mouse. Planta Medica 1985; 51: 28-31.
2. Woerdenbag HJ, Meijer C, Mulder NH, Vries EGE de, Hendriks H, Malingré ThM.
Evaluation of the in vitro cytotoxicity of some sesquiterpene lactones on a human lung
carcinoma cell line using the fast green dye exclusion assay. Planta Medica 1986; 52: 112114.
3. Woerdenbag HJ. Eupatorium cannabinum L. A review emphasizing the sesquiterpene
lactones and their biological activity. Pharmaceutisch Weekblad Scientific Edition 1986; 8:
245-251.
4. Woerdenbag HJ, Lemstra W, Hendriks H, Malingré ThM, Konings AWT. Investigation of
the anti-tumour action of eupatoriopicrin against the Lewis lung tumour. Planta Medica
1987; 53: 318-322.
5. Woerdenbag HJ, Malingré ThM, Lemstra W, Konings AWT. Cytostatic activity of
eupatoriopicrin in fibrosarcoma bearing mice. Phytotherapy Research 1987; 1: 76-79.
6. Woerdenbag HJ, Malingré ThM, Lemstra W, Konings AWT. Reduced levels of glutathione
in liver and tumour tissue of the mouse after administration of eupatoriopicrin. Phytotherapy
Research 1988; 2: 80-84.
7. Woerdenbag HJ, Hendriks H, Malingré ThM, Stralen R van, Berg KJ van den, Konings
AWT. In vitro cytotoxicity of sesquiterpene lactones from Eupatorium cannabinum L. and
semi-synthetic derivatives from eupatoriopicrin. Phytotherapy Research 1988; 2: 109-114.
8. Woerdenbag HJ, Lemstra W, Malingré ThM, Konings AWT. Enhanced cytostatic activity of
the sesquiterpene lactone eupatoriopicrin after glutathione depletion. British Journal of
Cancer 1989; 59: 68-75.
9. Woerdenbag HJ, Linde JCC van der, Kampinga HH, Malingré ThM, Konings AWT.
Induction of DNA damage in Ehrlich ascites tumour cells by exposure to eupatoriopicrin.
Biochemical Pharmacology 1989; 38: 2279-2283.
10. Woerdenbag HJ, Edwards ACM, Budé EJM, Malingré ThM, Konings AWT.
Eupatoriopicrin-induced lipid peroxidation in liver and tumour tissue of the mouse.
Biochemical Pharmacology 1989; 38: 3115-3118.
11. Woerdenbag HJ. A fundamental study on the cytostatic action of sesquiterpene lactones
from Eupatorium cannabinum L. Pharmaceutisch Weekblad Scientific Edition 1989; 11: 6768.
12. Woerdenbag HJ, Pras N, Frijlink HW, Lerk CF, Malingré ThM. Cyclodextrin-facilitated
bioconversion of 17-estradiol by a phenoloxidase from Mucuna pruriens cell cultures.
Phytochemistry 1990; 29: 1551-1554.
1
13. Woerdenbag HJ, Uden W van, Frijlink HW, Lerk CF, Pras N, Malingré ThM. Increased
podophyllotoxin production in Podophyllum hexandrum cell suspension cultures after
feeding coniferyl alcohol as a -cyclodextrin complex. Plant Cell Reports 1990; 9: 97-100.
14. Woerdenbag HJ, Lugt ChB, Pras N. Artemisia annua L.: a source of novel antimalarial
drugs. Pharmaceutisch Weekblad Scientific Edition 1990; 12: 169-181.
15. Pras N, Visser JF, Batterman S, Woerdenbag HJ, Malingré ThM, Lugt ChB. Laboratory
selection of Artemisia annua L. on high artemisinin yielding types. Phytochemical Analysis
1991; 2: 80-83.
16. Woerdenbag HJ, Pras N, Bos R, Visser JF, Hendriks H, Malingré ThM. Analysis of
artemisinin and related sesquiterpenoids from Artemisia annua L. by combined gas chromatography/mass spectrometry. Phytochemical Analysis 1991; 2: 215-219.
17. Uden W van, Homan B, Woerdenbag HJ, Pras N, Malingré ThM, Wichers HJ, Harkes M.
Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root
culture of Linum flavum. Journal of Natural Products 1992; 55: 102-110.
18. Woerdenbag HJ, Pras N, Uden W van, Boer A de, Batterman S, Visser JF, Malingré ThM.
High peroxidase activity in cell cultures of Artemisia annua with minute artemisinin
contents. Natural Product Letters 1992; 1: 121-128.
19. Woerdenbag HJ, Lüers JFJ, Uden W van, Pras N, Malingré ThM, Alfermann AW.
Production of the new antimalarial drug artemisinin in shoot cultures of Artemisia annua L.
Plant Cell, Tissue and Organ Culture 1993; 32: 247-257.
20. Linde JCC van der, Woerdenbag HJ, Malingré ThM, Kampinga HH, Konings AWT. Role
of membrane lipid composition in the cytotoxicity of the sesquiterpene lactone eupatoriopicrin. Phytotherapy Research 1993; 7: 128-133.
21. Woerdenbag HJ, Bos R, Salomons MC, Hendriks H, Pras N, Malingré ThM. Volatile
constituents of Artemisia annua L. (Asteraceae). Flavour and Fragrance Journal 1993; 8:
131-137.
22. Woerdenbag HJ, Moskal TA, Pras N, Malingré ThM, El-Feraly FS, Kampinga HH, Konings
AWT. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells.
Journal of Natural Products 1993; 56: 849-856.
23. Uden W van, Oeij H, Woerdenbag HJ, Pras N. Glucosylation of cyclodextrin-complexed
podophyllotoxin by cell cultures of Linum flavum L. Plant Cell, Tissue and Organ Culture
1993; 34: 169-175.
24. Pras N, Woerdenbag HJ, Batterman S, Visser JF, Uden W van. Mucuna pruriens:
improvement of the biotechnological production of the anti-Parkinson drug L-DOPA by
plant cell selection. Pharmacy World & Science 1993; 15: 263-268.
25. Teeyapant R, Woerdenbag HJ, Kreis P, Hacker J, Wray V, Witte L, Proksch P. Antibiotic
and cytotoxic activity of brominated compounds from the marine sponge Verongia
aerophoba. Zeitschrift für Naturforschung 1993; 48c: 939-945.
2
26. Woerdenbag HJ, Pras N, Nguyen GC, Bui TB, Bos R, Uden W van, Pham VY, Nguyen VB,
Batterman S, Lugt ChB. Artemisinin, related sesquiterpenes, and essential oil in Artemisia
annua during a vegetation period in Vietnam. Planta Medica 1994; 60: 272-275.
27. Woerdenbag HJ, Pras N, Uden W van, Wallaart TE, Beekman AC, Lugt ChB. Progress in
the research of artemisinin-related antimalarials: an update. Pharmacy World & Science
1994; 16: 169-180.
28. Woerdenbag HJ, Merfort I, Passreiter CM, Schmidt TJ, Willuhn G, Uden W van, Pras N,
Kampinga HH, Konings AWT. Cytotoxicity of flavonoids and sesquiterpene lactones from
Arnica species against the GLC4 and the COLO 320 cell lines. Planta Medica 1994; 60: 434437.
29. Uden W van, Woerdenbag HJ, Pras N. Cyclodextrins as a useful tool for bioconversions in
plant cell biotechnology. Plant Cell, Tissue and Organ Culture 1994; 38: 103-113.
30. Boersma HH, Woerdenbag HJ, Bauer J, Scheithauer W, Kampinga HH, Konings AWT.
Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human
colorectal cancer cell lines. Phytomedicine 1994; 1: 239-244.
31. Middel O, Woerdenbag HJ, Uden W van, Oeveren A van, Jansen JFGA, Feringa BL,
Konings AWT, Pras N, Kellogg RM. Synthesis and cytotoxicity of novel lignans. Journal of
Medicinal Chemistry 1995; 38: 2112-2118.
32. Smit HF, Woerdenbag HJ, Singh RH, Meulenbeld GJ, Labadie RP, Zwaving JH. Ayurvedic
herbal drugs with possible cytostatic activity. Journal of Ethnopharmacology 1995; 47: 7584.
33. Zhu Y-P, Woerdenbag HJ. Traditional Chinese herbal medicine. Pharmacy World &
Science 1995; 17: 103-112.
34. Woerdenbag HJ, Merfort I, Schmidt TJ, Passreiter CM, Willuhn G, Uden W van, Pras N,
Konings AWT. Decreased helenalin-induced cytotoxicity by flavonoids from Arnica as
studied in a human lung cancer cell line. Phytomedicine 1995; 2: 127-132.
35. Kolodziej H, Haberland C, Woerdenbag HJ, Konings AWT. Moderate cytotoxicity of
proanthocyanidins to human tumour cell lines. Phytotherapy Research 1995; 9: 410-415.
36. Uden W van, Bouma AS, Bracht Waker JF, Middel O, Wichers HJ, Waard P de, Woerdenbag HJ, Kellogg RM, Pras N. The production of podophyllotoxin and its 5-methoxy
derivative through bioconversion of cyclodextrin-complexed desoxypodophyllotoxin by
plant cell cultures. Plant Cell, Tissue and Organ Culture 1995; 42: 73-79.
37. Pras N, Woerdenbag HJ, Uden W van. Bioconversion potential of plant enzymes for the
production of pharmaceuticals. Plant Cell, Tissue and Organ Culture 1995; 43: 117-121.
38. Pras N, Woerdenbag HJ, Uden W van. The power of plant enzymes in bioconversions.
AgBiotech News and Information 1995; 7: 231N-243N.
39. Beekman AC, Woerdenbag HJ, Kampinga HH, Konings AWT. Cytotoxicity of artemisinin,
a dimer of dihydroartemisinin, artemisitene and eupatoriopicrin as evaluated by the MTT
and clonogenic assay. Phytotherapy Research 1996; 10: 140-144.
3
40. François G, Passreiter CM, Woerdenbag HJ, Looveren M van. Antiplasmodial activities and
cytotoxic effects of aqueous extracts and sesquiterpene lactones from Neurolaena lobata.
Planta Medica 1996; 62: 126-129.
41. Bos R, Woerdenbag HJ, Hendriks H, Zwaving JH, Smet PAGM de, Tittel G, Wikström HV,
Scheffer JJC. Analytical aspects of phytotherapeutic valerian preparations. Phytochemical
Analysis 1996; 7: 143-151.
42. Koulman A, Proksch P, Ebel R, Beekman AC, Uden W van, Pedersen JA, Konings AWT,
Pras N, Woerdenbag HJ. Cytotoxicity and mode of action of aeroplysinin-1 and a related
dienone from the sponge Aplysina aerophoba. Journal of Natural Products 1996; 59: 591594.
43. Bos R, Woerdenbag HJ, Hendriks H, Sidik, Wikström HV, Scheffer JJC. The essential oil
and valepotriates from roots of Valeriana javanica Blume grown in Indonesia. Flavour and
Fragrance Journal 1996; 11: 321-326.
44. Gören N, Woerdenbag HJ, Bozok-Johansson C. Cytotoxic and antibacterial activities of
sesquiterpene lactones isolated from Tanacetum praeteritum subsp. praeteritum. Planta
Medica 1996; 62: 419-422.
45. Woerdenbag HJ, Lutke LR, Bos R, Stevens JF, Hulst R, Kruizinga WH, Zhu Y-P, Elema
ET, Hendriks H, Uden W van, Pras N. Isolation of two cytotoxic diterpenes from the fern
Pteris multifida. Zeitschrift für Naturforschung 1996; 51c: 635-638.
46. Hendriks H, Bos R, Woerdenbag HJ. The essential oil of Tanacetum parthenium (L.)
Schulz-Bip. Flavour and Fragrance Journal 1996; 11: 367-371.
47. Beekman AC, Woerdenbag HJ, Uden W van, Pras N, Konings AWT, Wikström HV,
Schmidt TJ. Structure-cytotoxicity relationships of some helenanolide type sesquiterpene
lactones. Journal of Natural Products 1997; 60: 252-257.
48. Bos R, Woerdenbag HJ, Hendriks H, Smit HF, Wikström HV, Scheffer JJC. Composition of
the essential oil from roots and rhizomes of Valeriana wallichii DC. Flavour and Fragrance
Journal 1997; 12: 123-131.
49. Beekman AC, Barentsen ARW, Woerdenbag HJ, Uden W van, Pras N, Konings AWT, ElFeraly FS, Galal AM, Wikström HV. Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. Journal of Natural Products 1997; 60: 325-330.
50. Uden W van, Bos JA, Boeke GM, Woerdenbag HJ, Pras N. The large-scale isolation of
deoxypodophyllotoxin from rhizomes of Anthriscus sylvestris followed by its bioconversion
into 5-methoxypodophyllotoxin -D-glucoside by cell cultures of Linum flavum. Journal of
Natural Products 1997; 60: 401-403.
51. Kolodziej K, Kayser O, Woerdenbag HJ, Uden W van, Pras N. Structure-cytotoxicity
relationships of a series of natural and semi-synthetic simple coumarins as assessed in two
human tumour cell lines. Zeitschrift für Naturforschung 1997; 52c: 240-244.
52. Hendriks H, Anderson-Wildeboer Y, Engels G, Bos R, Woerdenbag HJ. The content of
parthenolide and its yield per plant during the growth of Tanacetum parthenium. Planta
Medica 1997; 63: 356-359.
4
53. Smit HF, Woerdenbag HJ, Zwaving JH, Singh RH, Labadie RP. Selection and evaluation of
Ayurvedic herbal drugs which might be useful in the treatment of malignant swellings.
Journal of the European Ayurvedic Society 1997; 5: 113-128.
54. Bos R, Woerdenbag HJ, Hendriks H, Scheffer JJC. Composition of the essential oils from
underground parts of Valeriana officinalis L. s.l. and several closely related taxa. Flavour
and Fragrance Journal 1997; 12: 359-370.
55. Bos R, Woerdenbag HJ, Hendriks H, Scheffer JJC. Occurrence of valerenic acid and
valepotriates in taxa related to Valeriana officinalis L. s.l. Scientia Pharmaceutica 1997; 65:
165-168.
56. Beekman AC, Woerdenbag HJ, Pras N, Uden W van, Konings AWT, Wikström HV.
Stability of artemisinin in aqueous environments: impact on its cytotoxic action to Ehrlich
ascites tumour cells. Journal of Pharmacy and Pharmacology 1997; 49: 1254-1258.
57. Bos R, Woerdenbag HJ, Hendriks H, Kruizinga WH, Herrema JH, Scheffer JJC. Methyl
valerenate, a new valerenane sesquiterpenoid in the essential oil from underground parts of
Valeriana officinalis L. s.l. Zeitschrift für Naturforschung C (A Journal of Biosciences)
1997; 52c: 858-860.
58. Bos R, Woerdenbag HJ, Putten FMS van, Hendriks H, Scheffer JJC. Seasonal variation of
the essential oil, valerenic acid and derivatives, and valepotriates in Valeriana officinalis
roots and rhizomes, and the selection of plants suitable for phytomedicines. Planta Medica
1998; 64: 143-147.
59. Bos R, Hendriks H, Scheffer JJC, Woerdenbag HJ. Cytotoxic potential of valerian
constituents and valerian tinctures. Phytomedicine 1998; 5: 219-225.
60. Levi M, Guchelaar H-J, Woerdenbag HJ, Zhu Y-P. Acute hepatitis in a patient using
Chinese herbal tea - a case report. Pharmacy World & Science 1998; 20: 43-44.
61. Beekman AC, Wierenga PK, Woerdenbag HJ, Uden W van, Pras N, Konings AWT, ElFeraly FS, Galal AM, Wikström HV. Artemisinin-derived sesquiterpene lactones as
potential antitumour compounds: cytotoxic action against bone marrow and tumour cells.
Planta Medica 1998; 64: 615-619.
62. Atopkina LN, Malinovskaya GV, Elyakov GB, Uvarova NI, Woerdenbag HJ, Koulman A,
Pras, N, Potier P. Cytotoxicity of natural ginseng glycosides and semisynthetic analogues.
Planta Medica 1999; 65: 30-34.
63. Koulman A, Pruijn LMC, Sandstra TSA, Woerdenbag HJ, Pras N. The pharmaceutical
exploration of cold water ascidians from the Netherlands: a possible source of new cytotoxic
natural products. Journal of Biotechnology 1999; 70: 85-88.
64. Wallaart TE, Uden W van, Lubberink HGM, Woerdenbag HJ, Pras N, Quax WJ. Isolation
and identification of dihydroartemisinic acid from Artemisia annua and its possible role in
the biosynthesis of artemisinin. Journal of Natural Products 1999; 62: 430-433.
5
65. Woerdenbag HJ, Bos R, Meeteren HE van, Baarslag JJJ, Jong-van den Berg LTW de, Pras
N, Rego Kuster G do, Petronia RRL, Vos GI. The essential oil of Croton flavens L.
(Welensali), a medicinal plant from Curaçao. Journal of Essential Oil Research 2000; 12:
667-671.
66. Bos R, Koulman A, Woerdenbag HJ, Quax WJ, Pras N. Volatile components from
Anthriscus sylvestris (L.) Hoffm. Journal of Chromatography A 2002; 966: 233-238.
67. Bos R, Woerdenbag HJ, Pras N. Determination of valepotriates. Journal of Chromatography
A 2002; 967: 131-146.
68. Dröge M, Bos R, Woerdenbag HJ, Quax WJ. Chiral gas chromatography for the
determination of 1,2-O-isopropylidene-sn-glycerol stereoisomers. Journal of Separation
Science 2003; 26: 771-776.
69. Koulman A, Kubbinga ME, Batterman S, Woerdenbag HJ, Pras N, Woolley JG, Quax WJ.
A phytochemical study of lignans in whole plants and cell suspension cultures of Anthriscus
sylvestris. Planta Medica 2003; 69: 733-738.
70. Woerdenbag HJ, Windono T, Bos R, Riswan S, Quax WJ. Composition of the essential oils
of Kaempferia rotunda L. and Kaempferia angustifolia Roscoe rhizomes from Indonesia.
Flavour and Fragrance Journal 2004; 19: 145-148.
71. Bos R, Stojanova AS, Woerdenbag HJ, Koulman A, Quax WJ. Volatile components of the
aerial parts of Artemisia pontica L. grown in Bulgaria. Flavour and Fragrance Journal 2005;
20: 145-148.
72. Elfahmi, Batterman S, Koulman A, Hackl T, Bos R, Kayser O, Woerdenbag HJ, Quax WJ.
Lignans from cell suspension cultures of Phyllanthus niruri, an Indonesian medicinal plant.
Journal of Natural Products 2006; 69: 55-58.
73. Vasilev NP, Julsing MK, Koulman A, Clarkson C, Woerdenbag HJ, Ionkova I, Bos R,
Jaroszewski JW, Kayser O, Quax WJ. Bioconversion of deoxypodophyllotoxin into
epipodophyllotoxin in E. coli using cytochrome P450 3A4. Journal of Biotechnology 2006;
126: 383-393.
74. Julsing MK, Koulman A, Woerdenbag HJ, Quax WJ, Kayser O. Combinatorial biosynthesis
of medicinal plant secondary metabolites. Biomolecular Engineering 2006; 23: 265-279.
75. Bos R, Windono T, Woerdenbag HJ, Boersma YL, Koulman A, Kayser O. HPLCphotodiode array detection analysis of curcuminoids in Curcuma species indegenous to
Indonesia. Phytochemical Analysis 2007; 18: 118-122.
76. Bos R, Woerdenbag HJ, Kayser O, Quax WJ, Ruslan K, Elfahmi. Essential oil constituents
of Piper cubeba L. fils. from Indonesia. Journal of Essential Oil Research 2007; 19: 14-17.
77. Elfahmi, Ruslan K, Batterman S, Bos R, Kayser O, Woerdenbag HJ, Quax WJ. Lignan
profile of Piper cubeba, an Indonesian medicinal plant. Biochemical Systematics and
Ecology 2007, 35: 397-402.
6
78. Julsing MK, Rijpkema M, Woerdenbag HJ, Kayser O, Quax WJ. Functional analysis of
genes involved in the biosynthesis of isoprene in Bacillus subtilis. Applied Microbiology
and Biotechnology 2007; 75: 1377-1384.
79. Julsing MK, Vasilev NP, Scheidman-Duhovny D, Muntendam R, Woerdenbag HJ, Quax
WJ, Wolfson HJ, Ionkova I, Kayser O. Metabolic stereoselectivity of cytochrome P450 3A4
towards deoxypodophyllotoxin: in silico predictions and experimental validation. European
Journal of Medicinal Chemistry 2008; 43: 1171-1179.
80. Staniek A, Woerdenbag HJ. Kayser O. Endophytes: exploiting biodiversity for the
improvement of natural product-based drug discovery. Journal of Plant Interactions 2008: 3:
75-93.
81. Julsing MK, Fichera MA, Maz F, Ebbelaar M, Bos R, Woerdenbag HJ, Quax WJ, Kayser O.
Bioconversion of mono- and sesquiterpenoids by recombinant human cytochrome P450
monoxygenases. Pharmaceutical Biology 2008; 46: 710-718.
82. Azizi M, Davareenejad G, Bos R, Woerdenbag HJ, Kayser O. Essential oil content and
constituents of black zira (Bunium persicum [Boiss.] B. Fedtsch.) from Iran during field
cultivation (domestication). Journal of Essential Oil Research 2009; 21: 78-82, 193-194.
83. Tu HAT, Woerdenbag HJ, Kane S, Riewpaiboon A, Hulst M van, Postma MJ. Economic
evaluations of hepatitis B vaccination for developing countries. Expert Review of Vaccines
2009; 8: 907-920.
84. Schellekens RCA, Olsder GG, Langenberg SMCH, Boer T, Woerdenbag HJ, Frijlink HW,
Kosterink JGW, Stellaard F. Proof-of-concept study on the suitability of 13C-urea as a
marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.
British Journal of Pharmacology 2009, 158: 532-540.
85. Aslan S, Kartal M, Kurucu S, Kuiper JM, Kruizinga WH, Bos R, Woerdenbag HJ, Kayser
O. Composition of the essential oil from roots and rhizomes of Valeriana phu L. growing
wild in Turkey. Journal of Essential Oil Research 2009; 21: 437-440.
86. Özbay Ö, Aslan S, Kartal M, Kurucu S, Bos R, Woerdenbag HJ, Kayser O. Preliminary
examination of the composition of the essential oil from roots and rhizomes of Valeriana
alpestris Stev. growing in Turkey. Journal of Essential Oil Research 2009; 21: 555-557.
87. Staniek A, Woerdenbag HJ, Kayser O. Taxomyces andreanae: a presumed paclitaxel
producer demystified? Planta Medica 2009; 75: 1561-1566.
88. Tu HAT, Bos JHJ, Woerdenbag HJ, Visser ST, Wilschut JC, Van Assen S, Jong-van den
Berg LTW de, Postma MJ. Results of a retrospective database analysis of drug utilization
and costs for treatment of chronic hepatitis B virus infection in the Northern Netherlands
between 2000 and 2006. Clinical Therapeutics 2010; 32: 133-144.
89. Staniek A, Muntendam R, Woerdenbag HJ, Kayser O. Essential oil constituents derived
from different organs of a relictual conifer Wollemia nobilis. Biochemical Systematics and
Ecology 2010; 38: 131-135.
7
90. Staniek A, Woerdenbag HJ, Kayser O. Screening the endophytic flora of Wollemia nobilis
for alternative paclitaxel sources. Journal of Plant Interactions 2010; 5: 189-195.
91. Schellekens RCA, Stellaard F, Olsder GG, Woerdenbag HJ, Frijlink HW, Kosterink JGW.
Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy
volunteers. Journal of Controlled Release 2010; 146: 334-340.
92. Hendrawati O, Woerdenbag HJ, Hille J, Kayser O. Metabolic engineering strategies for the
optimization of medicinal and aromatic plants: realities and expectations. Zeitschrift für
Arznei & Gewürzpflanzen (Journal of Medicinal & Spice Plants) 2010; 15: 111-126.
93. Elfahmi, Wirasutisna KR, Batterman S, Koulman A, Kayser O, Woerdenbag HJ, Quax WJ.
Reduced coniferin and enhanced 6-methoxypodophylotoxin production in Linum flavum cell
cultures. Pharmacognosy Journal 2010; 2: 74-80.
94. Tu HAT, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ. Economic
evaluations of rotavirus vaccination for developing countries: a review of the literature.
Expert Review of Vaccines 2011; 10: 1037-1051.
95. Hendrawati O, Woerdenbag HJ, Hille J, Quax WJ, Kayser O. Seasonal variations in the
deoxypodophyllotoxin content and yield of Anthriscus sylvestris L. (Hoffm.) grown in the
field and under controlled conditions. Journal of Agricultural and Food Chemistry 2011; 59:
8132-8139.
96. Hendrawati O, Woerdenbag HJ, Michiels PJA, Aantjes HG, Dam A van, Kayser O.
Identification of lignans and related compounds in Anthriscus sylvestris by LC-ESI-MS/MS
and LC-SPE-NMR. Phytochemistry 2011; 72: 2172-2179.
97. Schellekens RCA, Stellaard F, Woerdenbag HJ, Frijlink HW, Kosterink JGW. Applications
of stable isotopes in clinical pharmacology. British Journal of Clinical Pharmacology 2011;
72: 879-897.
98. Schellekens RCA, Baltink JH, Woesthuis EM, Stellaard F, Kosterink JGW, Woerdenbag
HJ, Frijlink HW. Film coated tablets (Colopulse technology) for targeted delivery in the
lower intestinal tract: influence of the core composition on release characteristics.
Pharmaceutical Technology and Development 2012; 17: 40-47.
99. Tu HAT, Rozenbaum MH, Coyte P, Li SC, Woerdenbag HJ, Postma MJ. Health economics
of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in
developing countries. Vaccine 2012; 30: 1521-1528.
100. Tu HAT, Vu HD, Rozenbaum MH, Woerdenbag HJ, Postma MJ. A review of the
literature on the economics on vaccination against TB. Expert Review of Vaccines 2012; 12:
303-317.
101. Hendrawati O, Quax WJ, Hille J, Woerdenbag HJ, Kayser O. In vitro regeneration of
wild chervil (Anthriscus sylvestris L.). In Vitro Cellular & Developmental Biology – Plant
2012; 48: 355-361.
8
102. Tu HAT, Vries R de, Woerdenbag HJ, Li SC, Le HH, Hulst M van, Postma MJ. Costeffectiveness analysis of hepatitis B immunization in Vietnam: application of costeffectiveness affordability curves in health care decision making. Value in Health Regional
Issues 2012; 1: 7-14.
103. Tu HAT, Woerdenbag HJ, Riewpaiboon A, Kane S, Le DP, Postma MJ, Li SC. Cost of
illness of chronic hepatitis B infection in Vietnam. Value in Health Regional Issues 2012; 1:
23-28.
104. Maurer JM, Schellekens RCA, Wutzke KD, Dijkstra G, Woerdenbag HJ, Frijlink HW,
Kosterink JGW, Stellaard F. A non-invasive, low-cost study design to determine the release
profile of colon delivery systems: a feasibility study. Pharmaceutical Research 2012; 29:
2010-2078.
105. Woerdenbag HJ, Nguyen TM, Vu DV, Tran H, Nguyen DT, Tran TV, De Smet PAGM,
Brouwers JRBJ. Vietnamese traditional medicine from a pharmacist’s perspective. Expert
Review of Clinical Pharmacology 2012; 5: 459-477.
106. Maurer JM, Schellekens RCA, Rieke HM van, Stellaard F, Wutzke KD, Buurman DJ,
Dijkstra G, Woerdenbag HJ, Frijlink, Kosterink JGW. ColoPulse tablets perform
comparably in healthy volunteers and Crohn's patients and show no influence of food and
time of food intake on bioavailability. Journal of Controlled Release 2013; 172: 618-624.
107. Elfahmi, Woerdenbag HJ, Kayser O. Jamu: Indonesian traditional herbal medicine
towards rational phytopharmacological use. Journal of Herbal Medicine 2014; 4: 51-73.
108.
Gechev TS, Hille J, Woerdenbag HJ, Benina M, Mehterov N, Toneva V, Fernie AR,
Mueller-Roeber B. Natural products from resurrection plants: potential for medical
applications. Biotechnology Advances 2014, in press. (DOI:
10.1016/j.biotechadv.2014.03.005)
9
Professional publications (peer reviewed)
1. Woerdenbag HJ, Lugt ChB, Pras N. Artemisinine en zijn derivaten: veelbelovende
antimalariamiddelen in ontwikkeling. [Artemisinin and its derivatives. Promising
antimalarial drugs in development.] Pharmaceutisch Weekblad 1991; 126: 320-323.
2. Woerdenbag HJ. Knoflook en knoflookpreparaten. [Garlic and garlic preparations.]
Pharmaceutisch Weekblad 1992; 127: 498-501.
3. Woerdenbag HJ. Therapie met bladextracten uit Ginkgo biloba. [Treatment with extracts
from Ginkgo biloba leaves.] Pharmaceutisch Weekblad 1993; 128: 102-106.
4. Woerdenbag HJ, De Smet PAGM, Scheffer JJC. Plantaardige geneesmiddelen in medischfarmaceutisch perspectief. [Herbal remedies in medical-pharmaceutical perspective.]
Pharmaceutisch Weekblad 1993; 128: 164-177.
5. Bos R, Woerdenbag HJ, Zwaving JH. Valeriaan en valeriaanpreparaten. [Valerian and
valerian preparations.] Pharmaceutisch Weekblad 1994; 129: 37-43.
6. Wijnsma R, Woerdenbag HJ, Molen J van der. Het gebruik van arnica in de fytotherapie.
[The phytotherapeutic use of arnica.] Pharmaceutisch Weekblad 1994; 129: 924-930.
7. Woerdenbag HJ, Koulman A, Proksch P, Ebel R, Uden W van, Pras N, Beijnen JH.
Farmacologisch actieve verbindingen uit mariene invertebraten: geneesmiddelen uit zee.
[Pharmacologically active compounds from marine invertebrates: drugs from the sea.]
Pharmaceutisch Weekblad 1995; 130: 1290-1301.
8. Woerdenbag HJ, Garritsen S, Uden W van, Pras N. De productie van farmacotherapeutisch
toegepaste natuurstoffen uit hogere planten. [The production of pharmacotherapeutically
applied natural products from higher plants.] Pharmaceutisch Weekblad 1997; 132: 10461060.
9. Woerdenbag HJ. Ginkgobladextract EGb 761 (Tavonin®). Pharmaceutisch Weekblad 1998;
133: 672-677.
10. Woerdenbag HJ, Movig KLL, Egberts ACG. De veiligheid van ‘intrigerende middelen’.
Zelfmedicatie bij erectiele disfunctie. [The safety of ‘impressive agents’. Self medication for
erectile disorders.] Pharmaceutisch Weekblad 1999; 134: 39-43.
11. Horsten SFAJ, Woerdenbag HJ. De zaagtandpalm schiet te hulp. Sabal, fytotherapeuticum
bij benigne prostaathyperplasie. [The saw palmetto dashes to help. Sabal, phytomedicine in
benign prostatic hyperplasia.] Pharmaceutisch Weekblad 1999; 134: 647-651.
12. Halkes SBA, Meer JH van, Woerdenbag HJ, Jans AL, Oussoren M, Tombe SF des, Kuy A
van der. Teelt en oogst beter controleren. Kwaliteit, veiligheid en werkzaamheid van
plantaardige medicinale bereidingen. [Culture and harvest need better control. Quality,
safety and efficacy of herbal medicinal products.] Pharmaceutisch Weekblad 2000; 135:
1260-1265.
13. Woerdenbag HJ, Oosterhuis B, Pras N, Kager PA, Vries PJ de. Artemotil (Artecef®). [Drug
profile: Artemotil (Artecef®).] Pharmaceutisch Weekblad 2000; 135: 1161-1165.
10
14. Woerdenbag HJ, Pras N, Meer JH van. De natuur als ongewisse leverancier.
Kwaliteitsborging en kwaliteitscontrole van fytotherapeutica. [Nature as an uncertain
supplier. Quality Assurance and quality control of medicinal plant compounds.]
Pharmaceutisch Weekblad 2001; 136: 635-639.
15. Kuy A van der, Woerdenbag HJ. Toetsing en toetsingscriteria. De werkzaamheid van
fytotherapeutica. [Evaluation and evaluation criteria. Efficacy of phytomedicines.]
Pharmaceutisch Weekblad 2001; 136: 647-650.
16. Woerdenbag HJ, Meer JH van, Kuy A van der. Bewijskracht in gradaties. Farmacotherapie
met fytotherapeutica. [Levels of evidence. Therapy with phytomedicines.] Pharmaceutisch
Weekblad 2001; 136: 652-657.
17. Maurer JM, Kouwen S, Woerdenbag HJ, Brouwers JRBJ, Kosterink JGW, Schellekens
RCA. Farmacotherapeutische rationaliteit van apotheekbereidingen: evaluatie en
toepasbaarheid van de LNA-procedure Farmacotherapeutische plaatsbepaling
apotheekbereiding. [Pharmacotherapeutic rationale of pharmacy drug compounding:
evaluation and applicability of the guideline from the Laboratory of Dutch Pharmacists
(LNA).] Pharmaceutisch Weekblad Wetenschappelijk Platform 2009; 3: 217-222.
18. Woerdenbag HJ, Dillingh JH, Wanders JTM, Boer EJ, Frijlink HW, Kosterink JGW,
Schellekens RCA. Elastomeer-infuuspompen getest voor de praktijk. [Elastomeric
infusion pumps tested for practice.] Pharmaceutisch Weekblad Wetenschappelijk Platform
2011; 5: 58-64 (a1117).
11
Chapters in books
1. Woerdenbag HJ. Eupatorium species. In: De Smet PAGM, Keller K, Hänsel R, Chandler
RF, eds. Adverse Effects of Herbal Drugs. Volume 2. Berlin: Springer-Verlag, 1993: 171194.
2. Woerdenbag HJ. Gossypol. In: De Smet PAGM, Keller K, Hänsel R, Chandler RF, eds.
Adverse Effects of Herbal Drugs. Volume 2. Berlin: Springer-Verlag, 1993: 195-208.
3. Uden W van, Pras N, Woerdenbag HJ. Linum species (flax): in vivo and in vitro
accumulation of lignans and other secondary metabolites. In: Bajaj YPS, ed. Biotechnology
in Agriculture and Forestry, Volume 26. Medicinal and Aromatic Plants VI. Berlin:
Springer-Verlag, 1994: 219-244.
4. Woerdenbag HJ, Uden W van, Pras N. Artemisia cina. In: De Smet PAGM, Keller K,
Hänsel R, Chandler RF, eds. Adverse Effects of Herbal Drugs. Volume 3. Berlin: SpringerVerlag, 1997: 15-22.
5. Woerdenbag HJ, Beek TA van. Ginkgo biloba. In: De Smet PAGM, Keller K, Hänsel R,
Chandler RF, eds. Adverse Effects of Herbal Drugs. Volume 3. Berlin: Springer-Verlag,
1997: 51-66.
6. Woerdenbag HJ, Uden W van, Pras N. Linum usitatissimum. In: De Smet PAGM, Keller K,
Hänsel R, Chandler RF, eds. Adverse Effects of Herbal Drugs. Volume 3. Berlin: SpringerVerlag, 1997: 89-98.
7. Bos R, Woerdenbag HJ, Smet PAGM de, Scheffer JJC. Valeriana species. In: De Smet
PAGM, Keller K, Hänsel R, Chandler RF, eds. Adverse Effects of Herbal Drugs. Volume 3.
Berlin: Springer-Verlag, 1997: 165-180.
8. Woerdenbag HJ, Bos R, Scheffer JJC. Valerian: quality assurance of the crude drug and its
preparations. In: Houghton PJ, ed. Valerian: The Genus Valeriana. Medicinal and Aromatic
Plants - Industrial Profiles. Amsterdam: Harwood Academic Publishers, 1997: 101-128.
9. Pras N, Woerdenbag HJ. Production of secondary metabolites by bioconversion. In:
Ramawat KG, Merillon JM, eds. Biotechnology - Secondary Metabolites. Jodhpur:
Scientific Publishers, 1999: 265-305.
10. Woerdenbag HJ, De Smet PAGM. Adverse effects and toxicity of ginkgo extracts. In: Beek
TA van, ed. Ginkgo biloba. Medicinal and Aromatic Plants - Industrial Profiles. Amsterdam:
Harwood Academic Publishers, 2000: 443-452.
11. Kuy A van der, Halkes SBA, Pos S, Woerdenbag HJ, Tombe SF des, Hebel LW von, Dijk H
van, Meer JH van. Fytotherapeutica. In: Timmerman H, Bergh Jeths A van den, eds.
Volksgezondheid Toekomst Verkenning 2002. Achtergrondstudie. Geneesmiddelen nu en in
de toekomst. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu (RIVM) 2001: 535540.
12. Woerdenbag HJ, Pras N. Analysis and quality control of commercial Artemisia species. In:
Wright CW, ed. Artemisia. Medicinal and Aromatic Plants - Industrial Profiles. London,
New York: Taylor & Francis, 2002: 51-77.
12
13. Pras N, Woerdenbag HJ. Production of secondary metabolites by bioconversion. In:
Ramawat KG, Merillon JM, eds. Biotechnology - Secondary Metabolites. Plants and
Microbes. Second Edition. Enfield, NH, USA: Science Publishers, 2007: 255-295.
14. Bouwman-Boer Y, Woerdenbag HJ. Stabiliteit. In: Bouwman-Boer Y, Le Brun PPH,
Oussoren C, Tel H, Woerdenbag HJ, eds. Recepteerkunde. Productzorg en bereiding van
geneesmiddelen. Houten: Bohn Stafleu Van Loghum; Den Haag: Koninklijke Nederlandse
Maatschappij ter Bevordering der Pharmacie (KNMP), 2009: 483-512.
15. Woerdenbag HJ, Bouwman Y, Frijlink HW. Wegen, meten en mengen. In: Bouwman-Boer
Y, Le Brun PPH, Oussoren C, Tel H, Woerdenbag HJ, eds. Recepteerkunde. Productzorg en
bereiding van geneesmiddelen. Houten: Bohn Stafleu Van Loghum; Den Haag: Koninklijke
Nederlandse Maatschappij ter Bevordering der Pharmacie (KNMP), 2009: 513-534.
16. Hendrawati O, Woerdenbag HJ, Hille J, Kayser O. Metabolic engineering of medicinal
plants and microorganisms for the production of natural products. In: Kayser O, Warzecha
H, eds. Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications. Second
Edition. Weinheim: Wiley-VHC Verlag GmbH & Co., KGaA, 2012: 491-526.
17. Võ Xuân Minh, Woerdenbag HJ, Frijlink HW. Chương 2. Dạng thuốc và đường dung.
[Chapter 2. Dosage forms and routes of administration.] In: Dược Lâm Sang. Tập I. Các
nguyên lý cơ bản trong dược lâm sang. [Handbook of Clinical Pharmacy. Volume I. General
principles in clinical pharmacy.] Hoàng Thị Kim Huyền, Brouwers JRBJ, eds. Hà Nợi: Nhà
Xuẩt Bản Y Học [Medical Publishing House], 2012: 37-67.
18. Võ Thành Phương Nhã, Woerdenbag HJ, Roon EN van. Chương 31. Bệnh da liễu. [Chapter
31. Dermatological diseases.] In: Dược Lâm Sang. Tập II. Sử dụng thuốc trong điều trị.
[Handbook of Clinical Pharmacy. Volume II. Drugs in use.] Hoàng Thị Kim Huyền,
Brouwers JRBJ, eds. Hà Nợi: Nhà Xuẩt Bản Y Học [Medical Publishing House], 2012: 483513.
19. Nguyễn Mạnh Tuyển, Woerdenbag HJ. Chương 33. Thuốc y học cổ truyền Việt Nam.
[Chapter 33. Traditional Vietnamese Medicine.] In: Dược Lâm Sang. Tập II. Sử dụng thuốc
trong điều trị. [Handbook of Clinical Pharmacy. Volume II. Drugs in use.] Hoàng Thị Kim
Huyền, Brouwers JRBJ, eds. Hà Nợi: Nhà Xuẩt Bản Y Học [Medical Publishing House],
2012: 541-557.
13
Books
1. Bouwman-Boer Y, Le Brun PPH, Oussoren C, Tel H, Woerdenbag HJ, eds.
Recepteerkunde. Productzorg en bereiding van geneesmiddelen. Houten: Bohn Stafleu Van
Loghum; Den Haag: Koninklijke Nederlandse Maatschappij ter Bevordering der Pharmacie
(KNMP), 2009.
2. Bakker P, Woerdenbag HJ, Gooskens V, Naafs B, Kaaij RM van der, Wieringa NF.
Dermatological Preparations for the Tropics. A formulary of dermatological preparations
and background information on therapeutic choices, production and dispensing. Groningen:
Beta Science Shop, University of Groningen, 2012.
Reports
1. Woerdenbag HJ. Technical Support in Developing Strategy for Enhancing the Quality of
Pharmaceutical Training. Ha Noi, Vietnam, 4-11 November 2006. Manila: WHO
Regional Office for the Western Pacific, 08 May 2008. WHO Report. No.
VTN/HRH/3.3/001 MR/2006/0510.
14
Proceedings
1. Woerdenbag HJ. Enkele farmacologische aspecten van valereenzuur, een sesquiterpenoïde
verbinding, geïsoleerd uit Valeriana officinalis L. s.l. In: Therapie met fytofarmaca.
Congresverslag 1985. Sluis WG van der, ed. Nederlandse Vereniging voor
Geneeskruidenonderzoek: Foliola 1985 (2): 29-37.
2. Woerdenbag HJ, Pras N, Uden W van. Production of the novel antimalarial drug artemisinin
using plants and cell cultures of Artemisia annua. In: Bruneton J, Guinaudeau H, eds. Actes
du Colloque: VIIe Colloque International Consacré aux Plantes Médicinales et Substances
d'Origine Naturelles. 1-4 June 1993. Angers: Université d'Angers, 1993: 62-69.
3. Woerdenbag HJ. Biologisch actieve inhoudsstoffen uit mariene sponzen. In: Mariene
organismen en hun toepassingen. Congresverslag 1994. Sluis WG van der, ed. Nederlandse
Vereniging voor Geneeskruidenonderzoek: Foliola 1994 (2): 23-34.
4. Bos R, Woerdenbag HJ. Analytical aspects of the essential oil, valerenic acid derivatives,
and valepotriates in Valeriana officinalis roots and rhizomes. In: Pank F, ed. Proceedings of
the International Symposium Breeding Research on Medicinal and Aromatic Plants. 30
June-4 July 1996. Quedlinburg: Bundesanstalt für Züchtungsforschung an Kulturpflanzen.
Beiträge zur Züchtungsforschung 1996; 2(1): 355-358.
5. Woerdenbag HJ. The role and research of phytomedicines in European countries. In:
Perhipba Komisariat Bogor, ed. Prosiding Simposium Penelitian Bahan Obat Alami VIII.
Bogor, 24-25 November 1994. Bogor: Perhimpunan Peneliti Bahan Obat Alami (Perhipba),
1997: 14-20.
6. Woerdenbag HJ. Cannabis als medicijn?! In: Farmacognostisch onderzoek. Congresverslag
1999. Sluis WG van der, ed. Nederlandse Vereniging voor Geneeskruidenonderzoek: Foliola
1999 (2): 51-58.
7. Woerdenbag HJ. Phytomedicines from plant to patient. In: Windono T, Sutaryadi, Joenoes
NZ, Sumiyani R, Palupi S, Wahyudi M, Parfati N, Yulia R, Budiono R eds. Prosiding
Seminar Nasional Tumbuhan Obat Indonesia XXI. Surabaya, 27-28 March 2002. Surabaya:
Fakultas Farmasi, Universitas Surabaya, 2002: 28-37.
8. Woerdenbag HJ. Advances in pharmacy education at the edge of high competition and
cooperation. In: Puttipipathkachorn S, ed. The Fifth Indochina Conference on
Pharmaceutical Sciences. Pharmacy for Sustainable Development. 21-24 November 2007.
Bangkok: Faculty of Pharmacy, Mahidol University, 2007: 45-46.
9. Azizi M, Bos R, Woerdenbag HJ, Kayser O. A comparative study of four Chamomile
cultivars cultivated in Iran. In: Šalamon I, ed. Proceedings of the First International
Symposium on Chamomile Research, Development and Production. Prešov (Slovakia), 7-10
June 2007. Louvain: International Society of Horticultural Science (ISHS), Acta
Horticulturae 2007; 749: 93-96.
15
10. Woerdenbag HJ, Visser JC, Frijlink HW. Pharmacy preparations, customized quality in
Dutch clinical care. In: The University of Medicine and Pharmacy at Ho Chi Minh City,
Vietnam, ed. Proceeding Pharma Indochina VIII. ASEAN Pharmacy – Integration for
Development. 4-5 December 2013. Nhà Xuẩt Bản Y Học (Medical Publishing House),
2013: 19-22.
16
Professional publications (other)
1. Bolt JB, Woerdenbag HJ, eds. Pharmaciae Sacrum 1881-1981. Lustrumboek, uitgegeven ter
gelegenheid van het honderdjarig bestaan van de Groningse Farmaceutische
Studentenvereniging Pharmaciae Sacrum. Groningen: Lustrumcommissie Pharmaciae
Sacrum 1981, 1982.
2. Woerdenbag HJ, Hendriks H, Bos R. Eupatorium cannabinum L. - Der Wasserdost oder
Wasserhanf. Neue Forschungen an einer alten Arzneipflanze. [Eupatorium cannabinum L.
The waterhemp modern research on an old medicinal plant.] Zeitschrift für Phytotherapie
1991; 12: 28-34.
3. Woerdenbag HJ, Pras N. Artemisia annua L. - Der einjährige Beifuß. Eine traditionelle
Arzneipflanze als Quelle für neue Antimalariamittel. [Artemisia annua L. The annual
wormwood. Chinese traditional medicinal plant as a source of new antimalarials.]
Zeitschrift für Phytotherapie 1991; 12: 133-139.
4. Bos R, Woerdenbag HJ, Hendriks H, Malingré ThM. Valeriana wallichii DC (= Valeriana
jatamansi Jones) - Der indische oder pakistanische Baldrian. [Portrait of a medicinal plant The Indian Valerian, Valeriana wallichii.] Zeitschrift für Phytotherapie 1992; 13: 26-34.
5. Woerdenbag HJ, Bos R, Hendriks H. Eupatorium perfoliatum L. - Der durchwachsene
Wasserhanf. [Eupatorium perfoliatum L. - The boneset.] Zeitschrift für Phytotherapie
1992; 13: 134-139.
6. Hendriks H, Bos R, Woerdenbag HJ. Der Rainfarn - eine potentielle Arzneipflanze?
[Tansy, a new medicinal plant?] Zeitschrift für Phytotherapie 1993; 14: 333-336.
7. Woerdenbag HJ. The role and research of phytomedicines in European countries.
Nederlands Tijdschrift voor Fytotherapie 1995; 8(1): 13-16.
8. Wijnsma R, Woerdenbag HJ, Busse W. Die Bedeutung von Arnika-Arten in der
Phytotherapie. [The importance of Arnica-species in phytomedicine.] Zeitschrift für
Phytotherapie 1995; 16: 48-62.
9. Uden W van, Woerdenbag HJ, Pras N. Cyclodextrin-facilitated bioconversions of apolar
phenol derivatives by plant cell cultures. Polyphénols Actualités 1996; no. 15: 11-14.
10. Woerdenbag HJ. De medicamenteuze behandeling van depressies: Hypericum als
alternatief. In: Hollander JM, ed. Depressie: ook een manier van benaderen. Amersfoort:
Mediselect BV, 1996: 10-14.
11. Woerdenbag HJ. Hypericumpreparaten als fyto-antidepressivum. Nederlands Tijdschrift
voor Fytotherapie 1997; 10(2): 4-7.
12. Woerdenbag HJ, Groot A de, Hollander JM, Meer JH van. Plantaardige laxeermiddelen: het
belang van ‘matigheid’ en van juiste informatie over gebruik en bijwerkingen. Nederlands
Tijdschrift voor Fytotherapie 1998; 11(1): 4-9.
13. Woerdenbag HJ. Farmacotherapie met ginkgo: veilig en effectief? Nederlands Tijdschrift
voor Fytotherapie 1999; 12(2): 9-12, 33.
17
14. Woerdenbag HJ, Meer JH van. Crataegus. Nederlands Tijdschrift voor Fytotherapie 2000;
13(3): 15-17.
15. Woerdenbag HJ, Meer JH van. Fytotherapeutica voor dermatologische toepassing. Een kort
overzicht van traditionele huidmiddelen. Nederlands Tijdschrift voor Fytotherapie 2001;
14(4): 2-3.
16. Woerdenbag HJ. Malaria. Over een tropische infectieziekte die steeds moeilijker te
behandelen is. Foliolum 2002; 15(3): 36-41.
17. Woerdenbag HJ. Phytomedicines from plant to patient. Artocarpus (Media Pharmaceutica
Indonesiana) 2002; 2: 11-19.
18. Frijlink HW, Woerdenbag HJ, eds. Self evaluation. Quality assessment of research
pharmaceutical sciences 1996-2001. Groningen: University of Groningen, 2003.
19. Windono T, Woerdenbag HJ, Bos R, Quax WJ, Riswan S. Perbandingan komponen kimia
minyak atsiri rimpang utama dan rimpang samping kunci pepit (Kaempferia rotunada L.).
Artocarpus (Media Pharmaceutica Indonesiana) 2003; 3: 45-52.
20. Woerdenbag HJ, Frijlink HW. Farmaceutisch wetenschappelijk onderzoek aan de RuG.
Foliolum 2004; 17(5): 11-22.
21. Doorne H van, Woerdenbag HJ, Trigt AM van, Franke JP, eds. Farmacie in Focus.
Zelfevaluatie opleidingen 2005. Groningen: Rijksuniversiteit Groningen, 2005.
22. Woerdenbag HJ. Kwaliteitszorg in het farmacieonderwijs. Foliolum 2005; 19(2): 7-11.
23. Schoonen AJM, Franke JP, Woerdenbag HJ. Een beeld van farmacie-onderwijs in
Groningen. In: 25e Lustrum der GFSV Pharmaciae Sacrum. Groningen: Pharmaciae
Sacrum, 2006: 16-19.
24. Woerdenbag HJ. Afrodisiaca uit de natuur: safe, sexy of suggestie? In: Sexy. 21e Almanak
der Groningse Farmaceutische Studentenvereniging Pharmaciae Sacrum. Groningen:
Pharmaciae Sacrum 2006, 22-28.
25. Schoonen AJM, Franke JP, Woerdenbag HJ. Een beeld van farmacie-onderwijs in
Groningen. In: Sexy. 21e Almanak der Groningse Farmaceutische Studentenvereniging
Pharmaciae Sacrum. Groningen: Pharmaciae Sacrum, 2006: 220-224.
26. Julsing MK, Woerdenbag HJ, Kayser O. Combinatoriële biosynthese. Plantenstoffen staan
weer volop in de belangstelling. Conceptuur 2007; no. 51: 6-7.
27. Moshage AJ, Westerink BHC, Woerdenbag HJ, Braun PG. A GUIDE to disease
mechanisms and drug development. Self evaluation 2003-2008. Graduate School GUIDE.
Groningen: University of Groningen, University Medical Center Groningen, 2009.
28. Woerdenbag HJ, Brouwers JRBJ. Traditionele geneeskunde in Vietnam. Nederlands
Tijdschrift voor Fytotherapie 2013; 26(1): 9-13.
29. Woerdenbag HJ, Moleman R. Zuurzak bij kanker: potentie of hoax? Nederlands Tijdschrift
voor Fytotherapie 2014; 27(1): 16-19.
18

Download Report